UnitedHealth Group Incorporated (NYSE:UNH) had its price target boosted by investment analysts at Morgan Stanley from $210.00 to $215.00 in a research note issued to investors on Thursday. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Morgan Stanley’s price target points to a potential upside of 10.96% from the company’s current price.

A number of other equities analysts have also commented on UNH. UBS AG reaffirmed a “buy” rating and issued a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. BidaskClub raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, June 9th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $205.00 price objective (up previously from $200.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. One analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $202.41.

Shares of UnitedHealth Group (NYSE:UNH) traded down 0.24% on Thursday, hitting $193.30. The company’s stock had a trading volume of 1,251,115 shares. UnitedHealth Group has a 52 week low of $132.39 and a 52 week high of $196.04. The company has a market cap of $186.89 billion, a price-to-earnings ratio of 23.22 and a beta of 0.64. The stock’s 50 day moving average is $190.13 and its 200-day moving average is $175.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 EPS for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter last year, the business posted $1.96 EPS. The company’s revenue was up 7.7% on a year-over-year basis. On average, equities research analysts anticipate that UnitedHealth Group will post $9.87 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Price Target Increased to $215.00 by Analysts at Morgan Stanley” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/08/17/unitedhealth-group-incorporated-unh-price-target-increased-to-215-00-by-analysts-at-morgan-stanley.html.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the sale, the director now directly owns 75,735 shares in the company, valued at approximately $13,832,240.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,540 shares of company stock worth $2,873,320. Insiders own 0.89% of the company’s stock.

Several hedge funds have recently modified their holdings of the stock. Raymond James Trust N.A. raised its stake in shares of UnitedHealth Group by 0.8% in the first quarter. Raymond James Trust N.A. now owns 55,809 shares of the healthcare conglomerate’s stock valued at $9,153,000 after buying an additional 456 shares during the period. Gulf International Bank UK Ltd raised its stake in shares of UnitedHealth Group by 2.9% in the first quarter. Gulf International Bank UK Ltd now owns 300,307 shares of the healthcare conglomerate’s stock valued at $49,253,000 after buying an additional 8,593 shares during the period. Quadrant Capital Group LLC raised its stake in shares of UnitedHealth Group by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 4,244 shares of the healthcare conglomerate’s stock valued at $684,000 after buying an additional 180 shares during the period. Country Club Trust Company n.a. acquired a new stake in shares of UnitedHealth Group during the first quarter valued at $202,000. Finally, National Pension Service raised its stake in shares of UnitedHealth Group by 2.2% in the first quarter. National Pension Service now owns 633,969 shares of the healthcare conglomerate’s stock valued at $104,599,000 after buying an additional 13,502 shares during the period. Institutional investors and hedge funds own 86.21% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.